Literature DB >> 17982718

Antimicrobial resistance in clinical isolates of Neisseria subflava from the oral cavities of a Japanese population.

Ryusaburo Furuya1, Yasuhiko Onoye, Akiko Kanayama, Takeshi Saika, Takako Iyoda, Mitsuhiro Tatewaki, Kaoru Matsuzaki, Intetsu Kobayashi, Masatoshi Tanaka.   

Abstract

A recent study indicated that Neisseria subflava, one of the commensal Neisseria species, may play an important role in the emergence of Neisseria gonorrhoeae strains with chromosomally mediated resistance to penicillin or cephalosporin by the horizontal genetic exchange of penA genes encoding the target site for penicillin or cephalosporin. The present investigation examined the antimicrobial susceptibility of 45 isolates of N. subflava from the oral cavities of Japanese men and women to various agents used for the treatment of gonococcal infections. Of the 45 isolates, 40 (88.9%) and 4 (8.8%) were intermediately resistant and resistant to penicillin, respectively, with the minimal inhibitory concentration (MIC)(50) and MIC(90) of penicillin being 0.5 mg/l and 1 mg/l, respectively. Of the 45 isolates, 13 (28.9%) and 14 (31.1%) were resistant to tetracycline and ciprofloxacin, respectively, and 3 (6.7%) showed reduced susceptibility to cefixime (although the susceptibility category was not determined). These results indicate that several isolates of N. subflava have acquired resistance or intermediate resistance to various antimicrobial agents, including penicillin, cephalosporin, tetracycline, and ciprofloxacin. The present study may thus confirm that N. subflava may be involved in the emergence of N. gonorrhoeae strains with either intermediate or total resistance to penicillin or cephalosporin by the horizontal genetic exchange of the penA gene.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17982718     DOI: 10.1007/s10156-007-0541-8

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  18 in total

Review 1.  Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.

Authors:  Magnus Unemo; William M Shafer
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

Review 2.  Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea.

Authors:  Magnus Unemo; Robert A Nicholas
Journal:  Future Microbiol       Date:  2012-12       Impact factor: 3.165

3.  Gonococcal resistance: are cephalosporins next?

Authors:  Robert D Kirkcaldy; Ronald C Ballard; Deborah Dowell
Journal:  Curr Infect Dis Rep       Date:  2011-04       Impact factor: 3.725

Review 4.  Applications of genomics to slow the spread of multidrug-resistant Neisseria gonorrhoeae.

Authors:  Tatum D Mortimer; Yonatan H Grad
Journal:  Ann N Y Acad Sci       Date:  2018-06-06       Impact factor: 5.691

5.  Comparison of antimicrobial susceptibilities of pharyngeal, rectal, and urethral Neisseria gonorrhoeae isolates among men who have sex with men.

Authors:  Sarah Kidd; Akbar Zaidi; Lenore Asbel; Tamara Baldwin; Beau Gratzer; Sarah Guerry; Roxanne P Kerani; Preeti Pathela; Kevin Pettus; Olusegun O Soge; Ali Stirland; Hillard S Weinstock
Journal:  Antimicrob Agents Chemother       Date:  2015-02-17       Impact factor: 5.191

6.  Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation.

Authors:  Avdhesh Kumar Rai; Madhusmita Panda; Ashok Kumar Das; Tashnin Rahman; Rajjyoti Das; Kishore Das; Anupam Sarma; Amal Ch Kataki; Indranil Chattopadhyay
Journal:  Arch Microbiol       Date:  2020-08-11       Impact factor: 2.552

7.  Reply to Laumen et al.

Authors:  Huan Vinh Dong; Paul C Adamson; Hoa Thi Nguyen; Trung Vu Nguyen; Giang Minh Le; Jeffrey D Klausner
Journal:  Clin Infect Dis       Date:  2021-01-27       Impact factor: 20.999

Review 8.  Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge.

Authors:  Magnus Unemo
Journal:  BMC Infect Dis       Date:  2015-08-21       Impact factor: 3.090

9.  Choosing New Therapies for Gonorrhoea: We Need to Consider the Impact on the Pan-Neisseria Genome. A Viewpoint.

Authors:  Chris Kenyon; Jolein Laumen; Sheeba Manoharan-Basil
Journal:  Antibiotics (Basel)       Date:  2021-05-01

10.  Antimicrobial Resistance Profiles of Human Commensal Neisseria Species.

Authors:  Maira Goytia; Symone T Thompson; Skylar V L Jordan; Kacey A King
Journal:  Antibiotics (Basel)       Date:  2021-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.